Companies formed

Since 1997, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and has spun out a new company every two months on average.

Over £2.1bn in external investment has been raised by Oxford University Innovation spinouts since 2010, and eleven are currently listed in London and New York.

The creation of new spinout companies, most of which are listed below, also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.

A company being established to commercialise Zooniverse technology

Incorporated in July 2018

Origin: Oxford University, Physics

AR/AV platform technology for software industry

Incorporated in October 2017

Origin: Oxford University, Engineering

Contact: Mark Mann

"CRIS" software that enables submission, de-identification and sharing of mental health patient records using a federated data and information governance model.

Incorporated in May 2019

Origin: Oxford University, Psychiatry

AnDy marries fine-engineering skills with a deep understanding of the fundamental mechanisms, to produce revolutionary machines that will change the shape of the future, taking inspiration from our environment in order to protect it, and capable of performance beyond anything currently found in nature or engineering.

Incorporated in April 2015

Origin: Oxford University, Department of Zoology

To develop compound libraries based on the asymmetric synthesis methodolofies.

Incorporated in March 2019

Origin: Oxford University, Chemistry

Aurox was established to research, develop, manufacture and commercially exploit products in the field of confocal microscopy and automated pathology slide scanners.

Incorporated in July 2006

Origin: Oxford University, Department of Engineering Science

Breath analysis

Incorporated in June 2004

Origin: Oxford University, Physical and Theoretical Chemistry

BioAnalab offers a contract testing service to the biopharmaceutical industry for the rapidly growing area of therapeutic monoclonal antibodies, with a longer-term strategy to develop diagnostics to measure levels of monoclonal antibodies and their immune response. In July 2009, BioAnaLab was acquired by Millipore Corp.

Incorporated in November 2002

Origin: Oxford University, Department of Pathology

Using phase change materials for smart glazing and displays.

Incorporated in November 2015

Origin: Oxford University, Department of Materials

Development of asthma monitoring system

Incorporated in November 2017

Origin: Oxford University, Engineering

Software development for a novel biomarker to detect coronary heart disease.

Incorporated in July 2018

Origin: Oxford University, Radcliffe department of medicine

Contact: James Groves

Advanced materials and technologies in safe, lightweight, high performance hydrogen storage technology.

Incorporated in January 2011

Origin: Oxford University, Science and Technology Facilities Council


Ready to get in touch?

Contact Us
© Oxford University Innovation